Pricing Log in Create free account

Azitra, Inc. (AZTR) vs NuCana PLC Sponsored ADR (NCNA)

Azitra, Inc. and NuCana PLC Sponsored ADR are both Biotechnology companies. Azitra, Inc. and NuCana PLC Sponsored ADR are of similar size ($4.4M and $4.3M). NuCana PLC Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.0×. Across the 11 metrics below, Azitra, Inc. leads on 6 and NuCana PLC Sponsored ADR on 5.

Valuation

Metric AZTR NCNA Biotechnology median
P/E 1.05 n/m 8.50
P/S 2.33 n/m 9.71
P/B 0.18 0.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.48 1.45 0.64
EV/Sales (9.26) n/m 9.21
Earnings yield 95.57% (226,311.31%) (33.15%)
Free cash flow yield (842.70%) (170,262.15%) (25.50%)

Profitability

Metric AZTR NCNA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) (68.70%) (56.36%)
Return on assets (190.69%) (45.24%) (48.04%)
Return on invested capital (1,272.49%) (1,130.23%) 0.00%

Growth

Metric AZTR NCNA Biotechnology median
Revenue growth (TTM) 58.18% — 6.02%
EPS growth (last fiscal year) 85.67% 98.96% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR NCNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 4.73 4.72
Net debt to EBITDA 0.20 1.23 0.96

Dividend

Metric AZTR NCNA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AZTR NCNA Biotechnology median
Market cap 4.33m 4.40m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack